“FREE”. 5,6-E E T. 8,9-E E T. 1 1 , 1 2-E E T. 1 4 , 1 5-E E T. ↑ C a2+ influx
vasodilation ... Know the 4 major enzyme pathways for production of arachidonic
acid ...
The Arachidonic Acid Cascade
Sandra P. Welch, Ph.D. Professor Pharmacology & Toxicology S m i t h 7 3 4 , 8 2 8-8 4 2 4 , s w e l c h @ h s c . v c u . e d u
A r a c h i d o n i c A c i d M e t a b o l i s m - S y n t h e s i s a n d A c t i o n o f P r o s t a g l a n d i n s ( P G s ) , T h r o m b o x a n e ( T x ), Leukotrienes (LTs), Epoxyeicosatrienoic Acids (EETs) and Anandamide glutamic acid
“B O U N D ” PHOSPHOLIPID ARACHIDONIC ACID
leukotriene C
glycine
LTD
4
Learning Objectives: After studying this material, the student LTE
4
LT receptor blockers
4
leukotriene B 4 ( d i h y d r o x y ) ↑ chemotaxis
neurotransmitters
PH
ACh, NE, etc. bradykinin
+
thrombin trauma
Epoxyeisatrienoic
↑ vascular permeability ↑ neutrophil secretion
b r o n c h . s.m. contraction
Acids (EETs) ↑ C a2+ i n f l u x
O
SP
others
glutathione
H
O
IP
AS
vasodilation i n h i b N a-K A T P a s e mitogenic
5 LO inhibitor HPETE
L
antiinflammatory steroids “B l i s s ”
should:
↑ WBC stickiness
(Zafirlukast, Montelukast)
(z i l e u t o n )
5 -, 12-, or 15lipoxygenase (LO)
E
O2
K n o w t h e f a t t y a c i d p r e c u r s o r f r o m w h i c h t h e 2 -s e r i e s o f
p r o s t a g l a n d i n s ( P G2 ) i s m a d e .
8,9-E E T
“F R E E ”
enzyme uncertain
1.
5,6-E E T
P 4 5 0 monooxygenase “epoxygenase”
COOH
O2
1 1 , 1 2-E E T
2.
Know the 4 major enzyme pathways for production of
Anandamide 1 4 , 1 5-E E T
(arachidonyl
1 ( C O X -1) - constitutive
ethanolamine
ethanolamide)
O2
cycloA s p i r i n - irreversible O t h e r N S A I D s - reversible
oxygenase PGG2
Binds to marijuana ( ∆
9-
hydroperoxidase
THC)
P G Synthase 2 ( C O X -2), inducible, ↑ during inflammation
c y c l o o x e n a s e plus hydroperoxidase
receptor biologic effects
oxygen radicals
PGH2
biochemical/ physiological/
arachidonic acid metabolites.
i s o m e r a s e , reductase
s e l e c t i v e C O X -2 inhibitors, e.g. celecoxib (Celebrex ®) blocks only COX -2, therefore less GI and platelet effects
v a s c u l a t u r e - I 2 synthase
3.
Understand the actions of the enzymes phospholipase
and cyclooxygenase and how steroids, aspirin and aspirin substitutes affect these enzymes.
platelet - T x synthase ( P 4 5 0 )
behavioral effects
5.
P G E 2 , P G F 2 α, P G D 2 vasodilation
↓ gastric acid
↑ v a s c . permeability sensitize to pain
↑ gastric mucous C a2+ m o b i l i z a t i o n
↑ body temperature uterine contraction
↑ N a + H 2O excretion
P G I 2 (t
1
/2 = 5 m i n )
Thromboxane A
inhibits platelet aggregation vasodilation
2
(t
1
4.
/2 = 3 0 s e c )
induces platelet aggregation smooth muscle contraction
6 -k e t o-P G F 1 α
TxB2
+
stimulates
Understand the difference between cyclooxygenase 1
( C O X -1 ) a n d c y c l o o x y g e n a s e 2 ( C O X -2 ) . 6.
Know the importance of and the point at which oxygen
radicals are formed in the arachidonic acid metabolic pathway. 7.
Know the major cyclooxygenase products (no
structures required) and give the major known biological activity or activities of the more important cyclooxygenase products. 8.
Be able to describe the major effects of prostaglandins
in the CNS
Know the difference between how aspirin and aspirin
substitutes affect cyclooxygenase enzyme activity. blocks
9.
U n d e r s t a n d h o w P G E 2 , P G F2 a , P G I 2 a n d T x A 2 c a n
a f f e c t v a s c u l a r a n d n o n -v a s c u l a r s m o o t h m u s c l e t o n e . 10.
Know how prostaglandins affect gastric function.
11.
Understand how cyclooxygenase inhibitors and PGI 2
(p r o s t a c y c l i n ) a f f e c t p l a t e l e t f u n c t i o n a n d t h u s a f f e c t hemostasis . 12.
Be able to provide three lines of reasoning which
support the importance of prostaglandins in inflammation.
I. 13.
1930's
Know the name of the enzyme or enzyme
History Discovered by K u r z o k & Lieb
systems responsible for the synthesis of leukotrienes
Characterized and named by Goldblatt & von Euler,
and H E T E s and know the major biological effects of
thought substances came from prostate gland, hence the
the products of these enzyme systems.
n a m e p r o s t a g l a n d i n ( a b b r e v i a t e d P G) 1960
Bergstrom - elucidated chemical structure
1971
Vane - discovered that MOA of aspirin is
of PGs 14.
Be able to describe the role of lipoxygenase
products in immediate hypersensitivity reactions and
inhibition of PG formation
asthma. Also know the major lipoxygenase enzyme
mid 1970s - 80s
inhibitor and the major antagonist of the leukotriene
S a m u e l s s o n - elucidated
structure of t h r o m b o x a n e and lipoxygenase metabolites
receptor.
1982
Bergstrom, Vane & S a m u e l s s o n share
Nobel Prize for work in elucidation of the "Arachidonic 15.
Acid Cascade"
Be aware of the possible role and function of
1980’s Epoxygenase pathway elucidated and
anandamide (arachidonyl ethanolamide) on
functions studied
cannabinoid (marijuana) receptors.
1992
Anandamide (arachidonyl ethanolamide)
discovered
II.
Function
III.
Substrates
Formed from polyunsaturated fatty acids Modulation of cell function Arachidonic acid metabolites are found in virtually all cells and tissues. Each cell type appears to have a characteristic
(PUFA). Phospholipases release the PUFA precursors
balance of metabolites.
from phospholipids.
C o m p o u n d s a r e s y n t h e s i z e d locally , o n d e m a n d , a n d
These PUFA can then be metabolized by
are not stored for future release.
cyclooxygenase, lipoxygenase enzymes or
T h e y act locally i n t h e a r e a i n w h i c h t h e y a r e f o u n d
P 4 5 0 “ e p o x y g e n a s e ”.
and in general do not have distant sites of action, as do many other types of chemical modulators or hormones.
III. 20:3
Substrates IV.
(di -h o m o -g -l i n o l e n i c a c i d ) , n o t v e r y p r e d o m i n a n t i n
n a t u r e , f o r m s P G1 20:4
Synthesis of Arachidonic Acid Metabolites
(a r a c h i d o n i c a c i d , e i c o s a t e t r a e n o i c a c i d ) f o r m s P G2 , 2 double bonds, predominant in nature. Metabolites of eicosatetraenoic acid are referred to as ‘eicosanoids”.
A. 20:5
(e i c o s a p e n t a e n o i c a c i d ) f o r m s P G3 , 3 double bonds. Eicosapentaenoic acid (EPA)
abundant in fish oil and increased in those who consume increased amounts of fish. Eicosapentaenoic acid can compete with arachidonic acid for enzyme metabolism. Increased EPA reduces formation of the P G2 s e r i e s .
Four General Pathways of Arachidonic Acid Product Formation
A r a c h i d o n i c A c i d M e t a b o l i s m - S y n t h e s i s a n d A c t i o n o f P r o s t a g l a n d i n s ( P G s ) , T h r o m b o x a n e ( T x ), Leukotrienes (LTs), Epoxyeicosatrienoic Acids (EETs) and Anandamide glutamic acid
“B O U N D ” PHOSPHOLIPID ARACHIDONIC ACID
leukotriene C
1.
glycine
LTD
4
LTE
4
4
LT receptor blockers
leukotriene B 4 ( d i h y d r o x y ) ↑ chemotaxis
PH
ACh, NE, etc. bradykinin
+
thrombin
↑ vascular permeability ↑ neutrophil secretion
b r o n c h . s.m. contraction
Epoxyeisatrienoic
c y c l o o x y g e n a s e 2 ( C O XX- 2 ) .
Acids (EETs)
C O XX- 1 i s
↑ C a2+ i n f l u x
O
trauma
SP
glutathione
H
others
O
L
IP
AS
vasodilation i n h i b N a-K A T P a s e mitogenic
5 LO inhibitor HPETE
antiinflammatory steroids “B l i s s ”
2
↑ WBC stickiness
(Zafirlukast, Montelukast)
neurotransmitters
c y c l o o x y g e n a s e – 2 i s o f o r m s, c y c l o o x y g e n a s e 1 ( C O XX- 1 ) a n d
(z i l e u t o n )
normally present in brain and kidney and is
5,6-E E T
5 -, 12-, or 15lipoxygenase (LO)
E
n o r m a l l y p r e s e n t i n m o s t t i s s u e s . C O XX- 2 i s
O2
8,9-E E T
“F R E E ”
enzyme uncertain
P 4 5 0 monooxygenase “epoxygenase”
COOH
O2
induced in most tissues during inflammation
1 1 , 1 2-E E T
Anandamide 1 4 , 1 5-E E T
(arachidonyl
1 ( C O X -1) - constitutive
ethanolamine
ethanolamide)
Binds to m a r i j u a n a ( ∆ 9- T H C )
O2
1
4
A s p i r i n - irreversible O t h e r N S A I D s - reversible
oxygenase
P G Synthase -
PGG2
2 ( C O X -2), inducible, ↑ during inflammation
hydroperoxidase
and injury.
3
cyclo-
c y c l o o x e n a s e plus hyfroperoxidase
receptor biologic effects
oxygen radicals
s e l e c t i v e C O X -2 inhibitors, e.g. celecoxib (Celebrex ®) blocks only COX -2, therefore less GI and platelet effects
PGH2
biochemical/ physiological/
i s o m e r a s e , reductase
v a s c u l a t u r e - I 2 synthase
platelet - T x synthase ( P 4 5 0 )
behavioral effects
P G E 2 , P G F 2 α, P G D 2
P G I 2 (t
vasodilation
↓ gastric acid
↑ v a s c . permeability sensitize to pain
↑ gastric mucous C a2+ m o b i l i z a t i o n
↑ body temperature uterine contraction
↑ N a + H 2O excretion
1
/2 = 5 m i n )
Thromboxane A
inhibits platelet aggregation vasodilation
2
(t
1
/2 = 3 0 s e c )
induces platelet aggregation smooth muscle contraction blocks
6 -k e t o-P G F 1 α
TxB2
+
stimulates
A r a c h i d o n i c A c i d M e t a b o l i s m - S y n t h e s i s a n d A c t i o n o f P r o s t a g l a n d i n s ( P G s ) , T h r o m b o x a n e ( T x ), Leukotrienes (LTs), Epoxyeicosatrienoic Acids (EETs) and Anandamide glutamic acid
“B O U N D ” PHOSPHOLIPID ARACHIDONIC ACID
leukotriene C
glycine
LTD
4
LTE
4
LT receptor blockers
4
leukotriene B 4 ( d i h y d r o x y ) ↑ chemotaxis ↑ WBC stickiness
(Zafirlukast, Montelukast)
neurotransmitters
PH
ACh, NE, etc. bradykinin
+
thrombin trauma
Cyclooxygenase
Arachidonic Acid
O
SP
glutathione
H
O
5 LO inhibitor HPETE
L
IP
AS
antiinflammatory steroids
vasodilation i n h i b N a-K A T P a s e mitogenic
(z i l e u t o n )
E
O2
8,9-E E T
“F R E E ”
enzyme uncertain
•O O
5,6-E E T
5 -, 12-, or 15lipoxygenase (LO)
“P
ro S y stag nt l h a and s e in ” Cyclooxygenase
Acids (EETs) ↑ C a2+ i n f l u x
others
“B l i s s ”
Epoxyeisatrienoic
↑ vascular permeability ↑ neutrophil secretion
b r o n c h . s.m. contraction
P 4 5 0 monooxygenase “epoxygenase”
COOH
O2
1 1 , 1 2-E E T
Anandamide 1 4 , 1 5-E E T
(arachidonyl
O
1 ( C O X -1) - constitutive
ethanolamine
ethanolamide)
O2
cycloA s p i r i n - irreversible O t h e r N S A I D s - reversible
oxygenase PGG2
Binds to
hydroperoxidase
m a r i j u a n a ( ∆ 9- T H C )
O
P G Synthase 2 ( C O X -2), inducible, ↑ during inflammation
c y c l o o x e n a s e plus hydroperoxidase
biologic effects
oxygen radicals
PGH2
biochemical/ physiological/
i s o m e r a s e , reductase
s e l e c t i v e C O X -2 inhibitors, e.g. celecoxib (Celebrex ®) blocks only COX -2, therefore less GI and platelet effects
v a s c u l a t u r e - I 2 synthase
Hydroperoxidase
O OH
Pg G2
receptor
O
platelet - T x synthase ( P 4 5 0 )
behavioral effects
P G E 2 , P G F 2 α, P G D 2
P G I 2 (t
vasodilation
↓ gastric acid
↑ v a s c . permeability sensitize to pain
↑ gastric mucous C a2+ m o b i l i z a t i o n
↑ body temperature uterine contraction
↑ N a + H 2O excretion
1
/2 = 5 m i n )
inhibits platelet aggregation vasodilation
Thromboxane A
2
(t
1
/2 = 3 0 s e c )
O
induces platelet aggregation smooth muscle contraction blocks
6 -k e t o-P G F 1 α
TxB2
+
Pg H2
stimulates
OH
A r a c h i d o n i c A c i d M e t a b o l i s m - S y n t h e s i s a n d A c t i o n o f P r o s t a g l a n d i n s ( P G s ) , T h r o m b o x a n e ( T x ), Leukotrienes (LTs), Epoxyeicosatrienoic Acids (EETs) and Anandamide glutamic acid
“B O U N D ” PHOSPHOLIPID ARACHIDONIC ACID
2.
lipoxygenase
leukotriene C
glycine
LTD
4
LTE
4
LT receptor blockers
4
leukotriene B 4 ( d i h y d r o x y ) ↑ chemotaxis ↑ WBC stickiness
(Zafirlukast, Montelukast)
neurotransmitters
PH
ACh, NE, etc. bradykinin
+
thrombin trauma
Acids (EETs) ↑ C a2+ i n f l u x
O
SP
others
glutathione
H
O
IP
AS
vasodilation i n h i b N a-K A T P a s e mitogenic
5 LO inhibitor HPETE
L
antiinflammatory steroids “B l i s s ”
Epoxyeisatrienoic
↑ vascular permeability ↑ neutrophil secretion
b r o n c h . s.m. contraction
(z i l e u t o n )
5,6-E E T
5 -, 12-, or 15lipoxygenase (LO)
E
O2
8,9-E E T
“F R E E ”
enzyme uncertain
P 4 5 0 monooxygenase “epoxygenase”
COOH
O2
1 1 , 1 2-E E T
Anandamide 1 4 , 1 5-E E T
(arachidonyl
1 ( C O X -1) - constitutive
ethanolamine
ethanolamide)
O2
cycloA s p i r i n - irreversible O t h e r N S A I D s - reversible
oxygenase PGG2
Binds to
hydroperoxidase
m a r i j u a n a ( ∆ 9- T H C )
P G Synthase 2 ( C O X -2), inducible, ↑ during inflammation
c y c l o o x e n a s e plus lipoxygenase
receptor biologic effects
oxygen radicals
PGH2
biochemical/ physiological/
i s o m e r a s e , reductase
s e l e c t i v e C O X -2 inhibitors, e.g. celecoxib (Celebrex ®) blocks only COX -2, therefore less GI and platelet effects
v a s c u l a t u r e - I 2 synthase
platelet - T x synthase ( P 4 5 0 )
behavioral effects
P G E 2 , P G F 2 α, P G D 2 vasodilation
↓ gastric acid
↑ v a s c . permeability sensitize to pain
↑ gastric mucous C a2+ m o b i l i z a t i o n
↑ body temperature uterine contraction
↑ N a + H 2O excretion
P G I 2 (t
1
/2 = 5 m i n )
inhibits platelet aggregation vasodilation
Thromboxane A
2
(t
1
/2 = 3 0 s e c )
induces platelet aggregation smooth muscle contraction blocks
6 -k e t o-P G F 1 α
TxB2
+
stimulates
A r a c h i d o n i c A c i d M e t a b o l i s m - S y n t h e s i s a n d A c t i o n o f P r o s t a g l a n d i n s ( P G s ) , T h r o m b o x a n e ( T x ), Leukotrienes (LTs), Epoxyeicosatrienoic Acids (EETs) and Anandamide glutamic acid
“B O U N D ” PHOSPHOLIPID ARACHIDONIC ACID
leukotriene C
4
leukotriene B 4 ( d i h y d r o x y ) ↑ chemotaxis ↑ WBC stickiness
(Zafirlukast, Montelukast)
PH
ACh, NE, etc. bradykinin
P - 4 5 0 m o n o o x y g e n a s e “e p o x y g e n a s e ”
LTE
4
LT receptor blockers
neurotransmitters
3.
glycine
LTD
4
+
thrombin
Acids (EETs) ↑ C a2+ i n f l u x
O
trauma
SP
glutathione
H
others
O
IP
AS
vasodilation i n h i b N a-K A T P a s e mitogenic
5 LO inhibitor HPETE
L
antiinflammatory steroids “B l i s s ”
Epoxyeisatrienoic
↑ vascular permeability ↑ neutrophil secretion
b r o n c h . s.m. contraction
(z i l e u t o n )
5,6-E E T
5 -, 12-, or 15lipoxygenase (LO)
E
O2
8,9-E E T
“F R E E ”
enzyme uncertain
P 4 5 0 monooxygenase “epoxygenase”
COOH
O2
1 1 , 1 2-E E T
Anandamide 1 4 , 1 5-E E T
(arachidonyl
1 ( C O X -1) - constitutive
ethanolamine
ethanolamide)
O2
cycloA s p i r i n - irreversible O t h e r N S A I D s - reversible
oxygenase
P G Synthase -
PGG2
Binds to
2 ( C O X -2), inducible, ↑ during inflammation
hydroperoxidase
m a r i j u a n a ( ∆ 9- T H C )
c y c l o o x e n a s e plus lipoxygenase
receptor biologic effects
oxygen radicals
s e l e c t i v e C O X -2 inhibitors, e.g. celecoxib (Celebrex ®) blocks only COX -2, therefore less GI and platelet effects
PGH2
biochemical/ physiological/
i s o m e r a s e , reductase
v a s c u l a t u r e - I 2 synthase
platelet - T x synthase ( P 4 5 0 )
behavioral effects
P G E 2 , P G F 2 α, P G D 2
P G I 2 (t
vasodilation
↓ gastric acid
↑ v a s c . permeability sensitize to pain
↑ gastric mucous C a2+ m o b i l i z a t i o n
↑ body temperature uterine contraction
↑ N a + H 2O excretion
1
/2 = 5 m i n )
Thromboxane A
inhibits platelet aggregation vasodilation
2
(t
1
/2 = 3 0 s e c )
induces platelet aggregation smooth muscle contraction blocks
6 -k e t o-P G F 1 α
TxB2
+
stimulates
A r a c h i d o n i c A c i d M e t a b o l i s m - S y n t h e s i s a n d A c t i o n o f P r o s t a g l a n d i n s ( P G s ) , T h r o m b o x a n e ( T x ), Leukotrienes (LTs), Epoxyeicosatrienoic Acids (EETs) and Anandamide glutamic acid
“B O U N D ” PHOSPHOLIPID ARACHIDONIC ACID
leukotriene C
anandamide
LTE
4
LT receptor blockers
4
leukotriene B 4 ( d i h y d r o x y ) ↑ chemotaxis ↑ WBC stickiness
(Zafirlukast, Montelukast)
neurotransmitters
4.
glycine
LTD
4
PH
ACh, NE, etc. bradykinin
+
thrombin trauma
Acids (EETs) ↑ C a2+ i n f l u x
O
SP
others
glutathione
H
O
IP
AS
vasodilation i n h i b N a-K A T P a s e mitogenic
5 LO inhibitor HPETE
L
antiinflammatory steroids “B l i s s ”
Epoxyeisatrienoic
↑ vascular permeability ↑ neutrophil secretion
b r o n c h . s.m. contraction
(z i l e u t o n )
5,6-E E T
5 -, 12-, or 15lipoxygenase (LO)
E
O2
8,9-E E T
“F R E E ”
enzyme uncertain
P 4 5 0 monooxygenase “epoxygenase”
COOH
O2
1 1 , 1 2-E E T
Anandamide 1 4 , 1 5-E E T
(arachidonyl
1 ( C O X -1) - constitutive
ethanolamine
ethanolamide)
O2
cycloA s p i r i n - irreversible O t h e r N S A I D s - reversible
oxygenase PGG2
Binds to
hydroperoxidase
m a r i j u a n a ( ∆ 9- T H C )
P G Synthase 2 ( C O X -2), inducible, ↑ during inflammation
c y c l o o x e n a s e plus lipoxygenase
receptor biologic effects
oxygen radicals
PGH2
biochemical/ physiological/
i s o m e r a s e , reductase
s e l e c t i v e C O X -2 inhibitors, e.g. celecoxib (Celebrex ®) blocks only COX -2, therefore less GI and platelet effects
v a s c u l a t u r e - I 2 synthase
platelet - T x synthase ( P 4 5 0 )
behavioral effects
B.
Synthesis and Action of
Prostaglandins, Thromboxane, Leukotrienes, Epoxyeicosatrienoic Acids and Anandamide
P G E 2 , P G F 2 α, P G D 2 vasodilation
↓ gastric acid
↑ v a s c . permeability sensitize to pain
↑ gastric mucous C a2+ m o b i l i z a t i o n
↑ body temperature uterine contraction
↑ N a + H 2O excretion
V.
P G I 2 (t
1
/2 = 5 m i n )
inhibits platelet aggregation vasodilation
Thromboxane A
2
(t
1
/2 = 3 0 s e c )
induces platelet aggregation smooth muscle contraction blocks
6 -k e t o-P G F 1 α
TxB2
+
Inhibitors of Arachidonic acid (AA) Metabolism
stimulates
A.
Cyclooxygenase Pathway
S u m m a r y o f t h e A c t i o n o f N o n-s e l e c t i v e v s . C O X -2 S e l e c t i v e I n h i b i t o r s
N o n -s t e r o i d a l a n t i -i n f l a m m a t o r y d r u g s ( N S A I D s ) i n h i b i t c y c l o o x y g e n a s e
C O X -1 & C O X -2 i n h i b i t o r s Aspirin (irreversible) & other (reversible) nonselective N o n -s t e r o i d a l a n t i -i n f l a m m a t o r y d r u g s (N S A I D s)
metabolism. Aspirin - irreversibly acetylates cyclooxygenase 1 and 2
C y c l o o x y g e n a s e 1 ( C O X -1) constitutive - m e a n i n g
Most other NSAIDs - reversibly, competitively inhibit cyclooxygenase 1 and 2
(– )
(– )
enzyme always there. Found in virtually all cells,
kidney), is induced to form in inflammatory cells during
including platelets and GI mucosa inhibitors, e.g. C e l e c o x i b (Celebrex ®)
( C e l e b r e x ® ) – r e v e r s i b l y , c o m p e t i t i v e l y , i n h i b i t C O X -2 , w h i c h i s n o r m a l l y i n f l a m m a t i o n . R e l a t i v e l y l i t t l e e f f e c t o n C O X -1 , w h i c h i s p r e s e n t i n m o s t
inflammation C O X -2 s e l e c t i v e
Selective cyclooxygenase 2 (COX - 2) inhibitors – Celecoxib present in brain and kidney and is induced in other tissues duri ng
C y c l o o x y g e n a s e 2 ( C O X -2) inducible, i.e. not present all the time (except brain &
(– )
R o f e c o x i b (V i o x x ®) Thromboxane A 2 (platelets → → aggregation)
Constitutive PGs (includes GI → → protective)
tissues and important to protect GI mucosa and induce platelet aggregation.
Induced PGs (includes pro -i n f l a m m a t o r y P G s )
Structures of Cyclooxygenase (COX) Isoenzymes COX-1
No Inhibition of COX-1 by Celecoxib at Therapeutic Concentrations COX-1
COX-2
Active site Active site
Active site
Hydrophobic channel
Arachidonic acid
“Side pocket” Hydrophobic channel N N
Celecoxib
Inhibition of COX-2 by Celecoxib COX-2 B.
Lipoxygenase Pathway
Agents which have been tested and found effective at reducing the occurrence of asthmatic symptoms and the need Active site
f o r b e t a -a g o n i s t s t o p r o d u c e b r o n c h i o l a r d i l a t i o n i n c l u d e
Celecoxib
z i l e u t o n (Z y f l o ® ) , a 5 -l i p o x y g e n a s e e n z y m e i n h i b i t o r, a n d N Arachidonic acid
z a f i r l u k a s t (A c c o l a t e ® ) a n d m o n t e l u k a s t (S i n g u l a i r ® ) ,
N
competitive leukotriene receptor blockers. “Side pocket”
A.
Nervous System
PgE 2 Facilitates
PGs are thought to be modulators of neuronal activity. They can increase or decrease
Stimulus
release of neurotransmitters and cause changes in
VI.
Biological Actions of Metabolites of Arachidonic Acid
Nociceptor
behavior.
PgE2
PGs can also sensitize pain receptors.
Hypothalamus
Anandamide binds to marijuana receptors and
IL-1ββ
causes analgesia and decreased locomotion. PGs given intraventricularly into the brain can induce
Inflammation
fever.
B.
1.
Smooth Muscle
Bronchial and Tracheal
L T C4 a n d L T D 4 a r e v e r y p o t e n t c o n t r a c t o r s o f a i r w a y
Vascular a.
2.
P G I2 i s t h e p r e d o m i n a n t P G p r o d u c e d b y
vascular tissue, mainly by e n d o t h e l i u m .
smooth muscle. The release of these compounds by leukocytes, resident macrophages or mast cells is important in generation of the
b.
PGI 2 a n d P G E 2
- relax muscle,
vasodilation c.
increased airway resistance in asthma and immediate hypersensitivity reactions.
T h r o m b o x a n e A 2 ( T x A 2 ) a n d L T C4 -
contracts
muscle, vasoconstriction
4.
Uterine
PGs cause contraction of uterine smooth muscle.
3.
GI PGs are approved for induction of abortion and also for i n d u c t i o n o f f u l l -t e r m l a b o r .
Generally PGs increase contraction and motility . This is often a side effect following the administration of PGs in other body areas.
Normal uterine production of PGs is thought to contribute to menstrual cramping. The NSAID ibuprofen is effective in reducing cramping. The MOA of this agent is likely the inhibition of formation of contractile PGs, in addition to ibuprofen's analgesic effect.
C.
Hemostasis 2.
1.
Vasculature
-
PGI 2 i s a v e r y p o t e n t i n h i b i t o r o f p l a t e l e t a g g r e g a t i o n
Blood platelets are prolific
induced by ADP, collagen or epinephrine.
metabolizers of AA.
Since PGI 2 is formed by the vascular wall PGI 2 is
P G e n d o p e r o x i d e s ( P G G2 , P G H2 ) a n d
hypothesized to be an important in vivo inhibitor of
T x A2 a r e p r o d u c e d b y p l a t e l e t s a n d
platelet aggregation.
t h e s e c o m p o u n d s induce platelets to adhere to one another, thus inducing
There is evidence that very low doses of oral aspirin (1/8 -
p l a t e l e t a g g r e g a t i o n. n.
1 / 4 t a b l e t ) m a y a c h i e v e a s e m i -s e l e c t i v e i n h i b i t i o n o f platelet but not arterial cyclooxygenase.
Aspirin and other NSAIDs (except
This would
m a x i m i z e t h e a n t i -t h r o m b o t i c e f f e c t o f a s p i r i n s i n c e P G I 2
selective COX - 2 inhibitors) double
inhibits platelet aggregation.
bleeding time because they inhibit the f o r m a t i o n o f t h e s e p r oo- a g g r e g a t o r y cyclooxygenase enzyme metabolites.
E.
GI Function
P G E 2 a n d P G I2 inhibit gastric acid secretion
D.
Kidney Function
T h e k i d n e y p a p i l l a i s r i c h i n A A . PGI 2 a n d P G E
induced by feeding, histamine or gastrin.
2
given into the
renal artery produce diuresis and increase Na+ and K+ e x c r e t i o n. n.
PGs also increase GI mucous secretion. I n h i b i t i o n o f P G s b y N S A I D s ( e x c e p t s e l e c t i v e C O X -2 i n h i b i t o r s ) w i l l t h e r e f o r e h a v e p r oo- u l c e r o g e n i c e f f e c t s
N S A I D s c a n a l t e r k i d n e y f u n c t i o n. n. T h e m e c h a n i s m s b y which PGs alter renal function are not certain, but likely involve redistribution of intrarenal blood flow and a change in tubular transport.
(increased acid, decreased mucous). F o r t h i s r e a s o n , s t a b l e P G a n a l o g s (M i s o p r o s t o l ® ) a r e n o w u s e d i n a n t i -u l c e r t h e r a p y . A l s o , s e l e c t i v e C O X -2 i n h i b i t o r s , w h i c h d o n o t d e c r e a s e G I s y n t h e s i s o f p r o t e c t i v e P G s b y C O X -1 , a r e a v a i l a b l e .
G. F.
Endocrine System
Exogenous PGs can stimulate the release of several hormones. However the exact role of PGs in endocrine function has not been adequately explored.
PGs are known,
however, to stimulate calcium metabolism and bone r e s o r p t i o n. n.
Inflammation
There is little doubt that arachidonic acid metabolites are important in inflammation. Evidence supporting this conclusion includes that: 1.
e x o g e n o u s P G s a n d LTs c a n p r o m o t e i n f l a m m a t i o n .
2.
P G s a n d L T s a r e f o u n d i n i n f l a m m a t o r y e x u d a t e s. s.
3.
drugs which inhibit cyclooxygenase, reduce inflammation.
Arachidonic acid metabolites contribute to inflammation by: 1.
increasing capillary permeability
2.
inducing local vasodilation and
H.
Commercial Preparations
thus redness 3.
promoting infiltration of inflammatory cells
4. p r o d u c t i o n o f t i s s u e i n j u r i n g o x y g e n f r e e r a d i c a l s d u r i n g t h e s y n t h e s i s o f P G s a n d LTs 5.
p r o d u c i n g i n f l a m m a t i o n -a s s o c i a t e d
hyperalgesia (increased pain)
1.
Aloprostadil (PGE1)
can be used in infants with congenital heart defects in order
2.
to increase pulmonary blood flow until definitive surgery can
C a r b o p r o s t ( 1 5 - m e t h y l P G F2 a )
be performed. induces second trimester abortion. It is a more powerful It is also marketed as Caverject® to treat penile erectile
uterine contractor than oxytocin. The methyl group is present to prevent oxidation.
dysfunction of neurogenic , vasculogenic or psychogenic origin. It causes erection by causing arterial dilation and occlusion of venous outflow.
D i n o p r o s t ( P G F2 a ) t r o m e t h a m i n e i s u s e d i n t r a -a m n i o t i c a l l y t o i n d u c e a b o r t i o n , u s u a l l y i n p r e g n a n c y o f
3.
longer than 15 weeks.
5.
Misoprostol (PGE1) and numerous P G a n a l o g s ( a r b a p r o s t i l , e n p r o s t i l , e n i s o p r o s t, t, deprostil , rioprostil, trimoprostil )
4. D i n o p r o s t o n e ( P G E2 ) i s u s e d i n s u p p o s i t o r y form to induce abortion in pregnancies of less than 28 weeks. I t i s a l s o u s e d t o i n d u c e f u l l -t e r m l a b o r .
inhibit gastric acid and stimulate gastric mucous secretion; this may be inversely related to the mechanism of the gastrointestinal damage that f o l l o w s e x p o s u r e t o n o n -s e l e c t i v e n o n s t e r o i d a l a n t i inflammatory drugs (NSAIDs).
These protective agents are used for the treatment of gastrointestinal ulceration by virtue of their cytoprotective effects on the gastric mucosa. 6. a.
Misoprostol is rapidly absorbed and metabolized in the liver and excreted in the urine. It has a halfhalf -life of less than 30 minutes.
b.
When administered chronically, misoprostol can prevent gastric ulceration caused by NSAIDs.
c.
Dose -related diarrhea can occur in as many as 40% of patients taking misoprostol misoprostol..
Latanoprost
- used for treatment of glaucoma,
acts by decreasing production of intraocular fluid. Works as well as timolol , but has side effect of turning blue eyes brown! Effectiveness and side effects of long term use is less certain.
d. Misoprostol is contraindicated for ulcers during pregnancy. It causes bleeding in 40% of women and, in a lower percentage, partial part ial or complete expulsion of the products of conception.
7.
The French abortion pill
M i f e p r i s t o n e ( R UU- 4 8 6 ,
“morning after pill”) must be taken within 9 weeks of the last m e n s t r u a l p e r i o d . R U -4 8 6 b l o c k s p r o g e s t e r o n e r e c e p t o r s causing the uterus to reject the implanted egg.
+
Drugs to Remember: A l o p r o s t a d i l ® M o n t e l u k a s t – S i n g u l a i r® M i s o p r o s t o l® C e l e c o x i b - C e l e b r e x ®
Two days after taking Mifeprestone the woman is given a prostaglandin which causes the cervix to soften and dilate and the uterus to contract and expel the embryo.
PGs are also
used similarly to induce uterine expulsion of the embryo after giving the cytotoxic agent methotrexate.
Recommended Reading: 1.
B a s i c a n d C l i n i c a l P h a r m a c o l o g y , B.G. K a t z u n g , 8th ed., 2001.
2.
Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 10th Edition, 2001.
Z i l e u t o n - Z y f l o®
R o f e c o x i b - V i o x x®
Zafirlukast - Accolate®